PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,5,5-trimethylcyclohex-3-en-1-one | 207-434-1 | 471-01-2 | - | - | - | - | 1 | - | - | - | - | Details |
| Calcium carbonate | 207-439-9 | 471-34-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Chenodeoxycholic acid | 207-481-8 | 474-25-9 | - | - | 1 | - | - | - | - | - | - | Details |
| 9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid | 207-521-4 | 478-43-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Diprophylline | 207-526-1 | 479-18-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 1,8-naphthylenediamine | 207-529-8 | 479-27-6 | - | - | 1 | - | - | - | - | - | - | Details |
| Cyclohex-1,2-ylenediaminetetra(acetic acid) | 207-582-7 | 482-54-2 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,2-dihydro-3H-indol-3-one | 207-586-9 | 482-89-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Fluoren-9-one | 207-630-7 | 486-25-9 | - | - | 1 | - | - | - | - | - | - | Details |
| 3-methyl-2-pent-2-enylcyclopent-2-enone | 207-668-4 | 488-10-8 | - | - | - | - | 1 | - | - | - | - | Details |
| 1-amino-1-deoxy-D-glucitol | 207-677-3 | 488-43-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Isomenthone | 207-727-4 | 491-07-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Quinazolin-4(1H)-one | 207-735-8 | 491-36-1 | - | - | 1 | - | - | - | - | - | - | Details |
| α-D-glucose | 207-757-8 | 492-62-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Carbonohydrazide | 207-837-2 | 497-18-7 | - | - | 3 | - | 1 | - | - | - | - | Details |
| Sodium carbonate | 207-838-8 | 497-19-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
| (1S)-3,7,7-trimethylbicyclo[4.1.0]hept-3-ene | 207-856-6 | 498-15-7 | - | - | 1 | - | - | - | - | - | - | Details |
| 8,9,10-trinorborn-2-ene | 207-866-0 | 498-66-8 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Cycloheptanone | 207-937-6 | 502-42-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Hexan-6-olide | 207-938-1 | 502-44-3 | - | - | 2 | - | - | - | - | - | - | Details |
| Cyclooctanone | 207-940-2 | 502-49-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Nonan-5-one | 207-946-5 | 502-56-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Cyclopentadecanone | 207-951-2 | 502-72-7 | - | - | 1 | - | 1 | - | - | - | - | Details |
| oxetane | 207-964-3 | 503-30-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Methanedisulphonic acid | 207-966-4 | 503-40-2 | - | - | - | - | 1 | - | - | - | - | Details |